The move to reclassify cannabis from a Schedule I to a Schedule III drug could spark new studies into pain, aging and women's health, Dr. Staci Gruber tells GBH's All Things Considered.

A German study found a marijuana-based drug reduced chronic back pain. The low-dose THC formula improved pain, sleep, and function. Researchers say it could be a safer alternative to opioids.

Marijuana may soon be rescheduled, and the biggest change could be taxes. Here’s how reclassification could lower tax bills ...

A large study of more than 4 million adults has found that people who use cannabis face nearly four times the risk of developing type 2 diabetes compared to those who don’t. The research, which ...

WASHINGTON (AP) — An experimental medication made from marijuana successfully reduced back pain in a new study, offering further support for the drug’s potential in treating one of the most common ...

An interesting new study suggests that people who use cannabis may have a much higher chance of getting type 2 diabetes than was thought before. Researchers say that people who use cannabis are four ...

Forbes contributors publish independent expert analyses and insights. Sarah Sinclair is an award-winning journalist covering cannabis. Experts believe VER-01, and other similar drugs, could be a ...

Cannabis products high in THC may provide short-term relief for chronic pain, while low-THC and CBD-only products show little ...

A recent study highlighted the prevalence of recreational drug use among American teenagers, revealing that an estimated 2.9 million Americans under 18 have used marijuana in recent years. The ...

Hemp is not what it used to be. Once dismissed as rope and rags, the hemp plant is now being redefined not just by its industrial potential but by its cannabinoid chemistry. To truly understand hemp ...